DR. PAUL P SZOTEK, M.D.
Radiology at Senate Blvd, Indianapolis, IN

License number
Indiana 258212
Category
Radiology
Type
Surgery
License number
Indiana 01063653A
Category
Radiology
Type
Surgery
Address
Address 2
1801 N Senate Blvd STE 635, Indianapolis, IN 46202
1542 S Bloomington St STE 635, Greencastle, IN 46135
Phone
(317) 963-1400
(317) 962-2595 (Fax)
(765) 658-2710
(765) 653-8686 (Fax)

Personal information

See more information about PAUL P SZOTEK at radaris.com
Name
Address
Phone
Paul Szotek
225 E 600 N, Valparaiso, IN 46383
Paul Szotek, age 48
465 Amhurst Rd, Valparaiso, IN 46385
Paul Szotek
5774 Volta Dr, Indianapolis, IN 46254
Paul M Szotek, age 54
225 600, Valparaiso, IN 46383
(219) 548-0162
Paul P Szotek
465 Amhurst Rd, Valparaiso, IN 46385

Organization information

See more information about PAUL P SZOTEK at bizstanding.com

Tower Surgical Inc

Indianapolis, IN

Industry:
General Surgeons, Surgeons, Hepatology, ...
Doing business as:
Tower Surgical Inc - Paul P Szotek MD<br>Tower Surgical
Registration:
1985
Phone:
(317) 923-7211 (Phone)
Description:
Tower Surgical employs 10 general surgeons and serves our patients at our 6 locations throughout the city. When indicated, procedures are performed at IU Health Methodist, IU Health West (in Avon) and...
Addresses:
1801 Senate Blvd, Indianapolis, IN 46202
1801 N Senate Ave, Indianapolis, IN 46202
Manager, Billing Managers:
Stephanie Banks (Secretary),James A. Crossin (Medical Doctor),Christopher M. Bearden (Medical Doctor),...
SIC:
8011 - Offices and Clinics of Doctors of Medicine
SIC6:
801199 - Offices and clinics of medical doctors, nec
Features:
Emergency Service
Licensed:
Yes
Senior discount:
No
Categories:
General Surgeons
Open Hours:
Mon 08.00 AM - 05.00 PM, Tue 08.00 AM - 05.00 PM, Wed 08.00 AM - 05.00 PM, ...
Company size:
23

Professional information

Paul Szotek Photo 1

General Surgeon

Position:
General Surgeon at Tower Surgical / IU Health
Location:
Indianapolis, Indiana
Industry:
Medical Practice
Work:
Tower Surgical / IU Health - Indianapolis, Indiana Area since Jan 2012 - General Surgeon Upstate Surgical Group Sep 2010 - Jan 2012 - General Surgeon Indiana University Jul 2002 - Jun 2010 - Resident Surgeon Massachusetts General Hospital - Greater Boston Area Jul 2004 - Aug 2007 - Research Fellow
Education:
Indiana University School of Medicine 2002 - 2010
MD, Medicine - General Surgery
Indiana University


Paul Patrick Szotek Photo 2

Paul Patrick Szotek, Indianapolis IN

Specialties:
Surgery
Work:
Tower Surgical
1801 Senate Blvd, Indianapolis, IN 46202 Tower Surgical Inc
1115 Rnld Rgn Pkwy, Avon, IN 46123
Education:
Indiana University(2002)


Paul Szotek Photo 3

Methods To Identify And Enrich For Populations Of Ovarian Cancer Stem Cells And Somatic Ovarian Stem Cells And Uses Thereof

US Patent:
2010027, Oct 28, 2010
Filed:
Jul 17, 2008
Appl. No.:
12/669136
Inventors:
Patricia K. Donahoe - Boston MA, US
Paul P. Szotek - Indianapolis IN, US
David T. MacLaughlin - Gloucester MA, US
Frederic Preffer - Cambridge MA, US
David Michael Dombkowski - Cambridge MA, US
Assignee:
THE GENERAL HOSPITAL CORPORATION - Boston MA
International Classification:
C12Q 1/04, C12N 5/09, C12Q 1/02, C12Q 1/68
US Classification:
435 6, 435366, 435 34, 435 29
Abstract:
The present invention relates to compositions and methods for treating, characterizing and diagnosing ovarian cancer. In particular, the present invention provides methods for treating and/or preventing ovarian cancer in a subject by administering to the subject an effective amount of Mullerian Inhibiting substance and/or an effective amount of an agent that inhibits BCRP1. The present invention further provides methods to identify and/or enrich for populations of ovarian cancer stem cells and populations of somatic ovarian stem cells, in particular, enrichment for populations of coelomic somatic ovarian stem cells, subcoelomic/stromal somatic ovarian stem cells and periphilar medullary somatic ovarian stem cells. The present invention also provides somatic ovarian stem cell markers and ovarian cancer stem cell markers, as well as methods to identify agents which selectively inhibit the proliferation of ovarian cancer stem cells as compared to somatic ovarian stem cells.